192 related articles for article (PubMed ID: 21667034)
1. Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium.
Cimpean AM; Poenaru Sava M; Raica M; Ribatti D
Oncol Rep; 2011 Nov; 26(5):1111-3. PubMed ID: 21667034
[TBL] [Abstract][Full Text] [Related]
2. Mucocele: a human model for lymphangiogenesis.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):222-8. PubMed ID: 18937525
[TBL] [Abstract][Full Text] [Related]
3. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of erythropoietin receptor in human pterygial tissues.
Kase S; Osaki M; Jin XH; Ohgami K; Yoshida K; Saito W; Takahashi S; Nakanishi K; Ito H; Ohno S
Int J Mol Med; 2007 Nov; 20(5):699-702. PubMed ID: 17912463
[TBL] [Abstract][Full Text] [Related]
5. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with vascular endothelial growth factor (VEGF) distribution.
Martín-López J; Pérez-Rico C; García-Honduvilla N; Buján J; Pascual G
Histol Histopathol; 2019 Aug; 34(8):917-929. PubMed ID: 30821336
[TBL] [Abstract][Full Text] [Related]
6. Increasing lymphatic microvessel density in primary pterygia.
Ling S; Liang L; Lin H; Li W; Xu J
Arch Ophthalmol; 2012 Jun; 130(6):735-42. PubMed ID: 22801834
[TBL] [Abstract][Full Text] [Related]
7. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
8. Neither normal nor diseased placentas contain lymphatic vessels.
Castro E; Tony Parks W; Galambos C
Placenta; 2011 Apr; 32(4):310-6. PubMed ID: 21316100
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma.
Heindl LM; Hofmann-Rummelt C; Adler W; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Apr; 117(4):649-58. PubMed ID: 20346821
[TBL] [Abstract][Full Text] [Related]
11. P63 expression in conjunctival proliferative diseases: pterygium and laryngo-onycho-cutaneous (LOC) syndrome.
Atkinson SD; Moore JE; Shah S; Sharma A; Best RM; Leccisotti A; Alarbi M; Rimmer D; Gardiner T; Moore TC
Curr Eye Res; 2008 Jul; 33(7):551-8. PubMed ID: 18600487
[TBL] [Abstract][Full Text] [Related]
12. Absence of lymphatic vessels in human dental pulp: a morphological study.
Gerli R; Secciani I; Sozio F; Rossi A; Weber E; Lorenzini G
Eur J Oral Sci; 2010 Apr; 118(2):110-7. PubMed ID: 20486999
[TBL] [Abstract][Full Text] [Related]
13. Distribution of vimentin-expressing cells in pterygium: an immunocytochemical study of impression cytology specimens.
Chen YT; Tseng SH; Tsai YY; Huang FC; Tseng SY
Cornea; 2009 Jun; 28(5):547-52. PubMed ID: 19421041
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
15. Distribution of lymphatic vessels in mouse thymus: immunofluorescence analysis.
Odaka C; Morisada T; Oike Y; Suda T
Cell Tissue Res; 2006 Jul; 325(1):13-22. PubMed ID: 16541287
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance.
Omachi T; Kawai Y; Mizuno R; Nomiyama T; Miyagawa S; Ohhashi T; Nakayama J
Cancer Lett; 2007 Feb; 246(1-2):167-72. PubMed ID: 16574316
[TBL] [Abstract][Full Text] [Related]
17. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
Fernández MI; Bolenz C; Trojan L; Steidler A; Weiss C; Alken P; Grobholz R; Michel MS
Eur Urol; 2008 Mar; 53(3):571-8. PubMed ID: 17804149
[TBL] [Abstract][Full Text] [Related]
19. Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.
Akhmetshina A; Beer J; Zwerina K; Englbrecht M; Palumbo K; Dees C; Reich N; Zwerina J; Szucs G; Gusinde J; Nevskaya T; Distler O; Kerjaschki D; Schett G; Distler JH
Arthritis Rheum; 2010 May; 62(5):1513-22. PubMed ID: 20155824
[TBL] [Abstract][Full Text] [Related]
20. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium.
Kase S; Takahashi S; Sato I; Nakanishi K; Yoshida K; Ohno S
Br J Ophthalmol; 2007 Jul; 91(7):958-61. PubMed ID: 17179165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
